http://www.pharmalot.com/2007/07/thailand-abbotts-deal-with-brazil-stinks/ News, Comment and Conversation Fri, 10 Feb 2012 19:34:18 +0000 http://wordpress.org/?v=2.6.2 http://www.pharmalot.com/2007/07/thailand-abbotts-deal-with-brazil-stinks/#comment-14950 BioResearcher Mon, 09 Jul 2007 00:00:58 +0000 http://www.pharmalot.com/2007/07/thailand-abbotts-deal-with-brazil-stinks/#comment-14950 Abbott and other drugmakers should just pull the plug on operations in Thailand and Brazil. Negotiating on these terms is a losing deal - clearly these countries are not working in good faith. Abbott et al seem bent on preventing the CL, but what's the point in doing so if the best you can do is a price barely above the generic rate? They'll never recoup their R&D at 5% above the cost to produce. I understand the logic that some revenue is better than no revenue, but these 'negotiations' will strip away any possibility of profit or even breakeven. Companies have been willing to essentially give away product in many lesser economies on the premise that one day they'll be able to negotiate 1st world rates. But now that many of these countries show no regard for patent protection there's no reason to hope for a brighter day. If Thailand and Brazil don't wish to fund the R&D of Abbott, then they shouldn't reap the rewards. Abbott and other drugmakers should just pull the plug on operations in Thailand and Brazil. Negotiating on these terms is a losing deal - clearly these countries are not working in good faith. Abbott et al seem bent on preventing the CL, but what’s the point in doing so if the best you can do is a price barely above the generic rate? They’ll never recoup their R&D at 5% above the cost to produce. I understand the logic that some revenue is better than no revenue, but these ‘negotiations’ will strip away any possibility of profit or even breakeven. Companies have been willing to essentially give away product in many lesser economies on the premise that one day they’ll be able to negotiate 1st world rates. But now that many of these countries show no regard for patent protection there’s no reason to hope for a brighter day. If Thailand and Brazil don’t wish to fund the R&D of Abbott, then they shouldn’t reap the rewards.

]]>